大塚ホールディングスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/02/21 | 5,018 | 5,022 | 4,961 | 4,989 | -73 | -1.4% | 1,293,400 |
2018/02/20 | 5,075 | 5,093 | 5,048 | 5,062 | -35 | -0.7% | 878,200 |
2018/02/19 | 5,010 | 5,100 | 5,000 | 5,097 | +131 | +2.6% | 1,169,600 |
2018/02/16 | 4,967 | 5,008 | 4,929 | 4,966 | +57 | +1.2% | 1,594,200 |
2018/02/15 | 4,741 | 4,944 | 4,741 | 4,909 | +206 | +4.4% | 2,194,300 |
2018/02/14 | 4,520 | 4,711 | 4,495 | 4,703 | +161 | +3.5% | 2,320,700 |
2018/02/13 | 4,641 | 4,655 | 4,525 | 4,542 | -80 | -1.7% | 1,266,100 |
2018/02/09 | 4,502 | 4,626 | 4,502 | 4,622 | -81 | -1.7% | 1,890,800 |
2018/02/08 | 4,648 | 4,727 | 4,648 | 4,703 | +108 | +2.4% | 1,304,200 |
2018/02/07 | 4,640 | 4,768 | 4,593 | 4,595 | +2 | ±0% | 1,597,000 |
2018/02/06 | 4,682 | 4,687 | 4,528 | 4,593 | -229 | -4.7% | 1,970,900 |
2018/02/05 | 4,871 | 4,919 | 4,814 | 4,822 | -108 | -2.2% | 1,183,200 |
2018/02/02 | 4,925 | 4,948 | 4,873 | 4,930 | -41 | -0.8% | 851,700 |
2018/02/01 | 4,856 | 4,975 | 4,851 | 4,971 | +125 | +2.6% | 1,014,200 |
2018/01/31 | 4,885 | 4,908 | 4,844 | 4,846 | -39 | -0.8% | 1,287,200 |
2018/01/30 | 4,932 | 4,958 | 4,878 | 4,885 | -40 | -0.8% | 908,700 |
2018/01/29 | 5,000 | 5,009 | 4,916 | 4,925 | -34 | -0.7% | 794,000 |
2018/01/26 | 4,958 | 5,000 | 4,936 | 4,959 | +50 | +1% | 1,326,700 |
2018/01/25 | 4,982 | 4,996 | 4,905 | 4,909 | -75 | -1.5% | 1,083,200 |
2018/01/24 | 4,957 | 4,991 | 4,945 | 4,984 | +26 | +0.5% | 732,200 |
2018/01/23 | 4,910 | 4,969 | 4,901 | 4,958 | +61 | +1.2% | 751,500 |
2018/01/22 | 4,904 | 4,939 | 4,874 | 4,897 | +9 | +0.2% | 854,900 |
2018/01/19 | 4,886 | 4,920 | 4,860 | 4,888 | +21 | +0.4% | 1,184,800 |
2018/01/18 | 4,895 | 4,930 | 4,854 | 4,867 | -24 | -0.5% | 1,244,800 |
2018/01/17 | 4,937 | 4,940 | 4,870 | 4,891 | -48 | -1% | 1,093,500 |
2018/01/16 | 4,965 | 4,986 | 4,932 | 4,939 | +3 | +0.1% | 648,900 |
2018/01/15 | 4,945 | 4,969 | 4,921 | 4,936 | -12 | -0.2% | 781,100 |
2018/01/12 | 4,995 | 5,012 | 4,942 | 4,948 | -74 | -1.5% | 1,116,000 |
2018/01/11 | 5,055 | 5,059 | 4,994 | 5,022 | -61 | -1.2% | 861,600 |
2018/01/10 | 5,050 | 5,096 | 5,043 | 5,083 | +33 | +0.7% | 872,100 |
2018/01/09 | 5,090 | 5,105 | 5,039 | 5,050 | -28 | -0.6% | 1,106,000 |
2018/01/05 | 5,040 | 5,079 | 5,006 | 5,078 | +38 | +0.8% | 999,800 |
2018/01/04 | 5,010 | 5,040 | 4,997 | 5,040 | +92 | +1.9% | 1,277,700 |
2017/12/29 | 4,977 | 4,988 | 4,943 | 4,948 | -23 | -0.5% | 525,900 |
2017/12/28 | 4,958 | 4,987 | 4,955 | 4,971 | +29 | +0.6% | 721,700 |
2017/12/27 | 4,950 | 4,957 | 4,918 | 4,942 | -73 | -1.5% | 766,000 |
2017/12/26 | 5,007 | 5,035 | 4,991 | 5,015 | +10 | +0.2% | 697,400 |
2017/12/25 | 5,000 | 5,017 | 4,977 | 5,005 | +12 | +0.2% | 555,800 |
2017/12/22 | 4,960 | 4,994 | 4,950 | 4,993 | +19 | +0.4% | 936,800 |
2017/12/21 | 4,981 | 5,004 | 4,961 | 4,974 | -19 | -0.4% | 864,400 |
2017/12/20 | 5,010 | 5,021 | 4,962 | 4,993 | -19 | -0.4% | 1,176,300 |
2017/12/19 | 5,050 | 5,057 | 5,010 | 5,012 | -35 | -0.7% | 758,900 |
2017/12/18 | 5,030 | 5,063 | 5,023 | 5,047 | +48 | +1% | 1,113,200 |
2017/12/15 | 4,969 | 5,028 | 4,948 | 4,999 | +18 | +0.4% | 1,825,800 |
2017/12/14 | 4,970 | 4,991 | 4,967 | 4,981 | +15 | +0.3% | 963,400 |
2017/12/13 | 4,980 | 4,984 | 4,949 | 4,966 | +18 | +0.4% | 939,800 |
2017/12/12 | 4,951 | 4,966 | 4,928 | 4,948 | +2 | ±0% | 899,600 |
2017/12/11 | 4,915 | 4,947 | 4,898 | 4,946 | +76 | +1.6% | 1,030,500 |
2017/12/08 | 4,793 | 4,876 | 4,790 | 4,870 | +7 | +0.1% | 2,472,900 |
2017/12/07 | 4,790 | 4,874 | 4,762 | 4,863 | +125 | +2.6% | 1,760,300 |
1651~
1700
件表示中 / 3412件
類似銘柄と比較する
現在ご覧いただいている「大塚HD」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
大塚HD | 891,000円 | +14.4% | +120.8% | 1.35% | 20.00倍 | 1.83倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
第一三共 | 443,500円 | +14.3% | +20.1% | 1.35% | 37.27倍 | 5.17倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
武 田 | 411,300円 | +5.1% | +76.2% | 4.77% | 95.87倍 | 0.94倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
アステラス薬 | 156,200円 | +12.2% | +180.3% | 4.74% | 55.93倍 | 1.83倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
塩野義 | 209,400円 | +5.7% | +3.9% | 2.74% | 10.42倍 | 1.38倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
市場注目の銘柄
チャート関連のコラム